Friday, July 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 28 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. US 7598420

    Rasagiline formulations and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted

  2. US 7598356

    Method for purifying a protein of the cystine-knot superfamily

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted

  3. US 7592343

    Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted

  4. US 7589100

    Non-hygroscopic and powdery amorphous pimecrolimus

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted

  5. US 7585622

    Increasing the proliferative capacity of cells using telomerase reverse transcriptase

    The Regents of the University of Colorado · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted

  6. US 7582641

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted

  7. US 7572834

    Rasagiline formulations and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted

  8. US 7572764

    Uses of chemically-modified cholinesterases for detoxification of organophosporus compounds

    State of Israel, Prime Minister's Office, Israel Insitute For Biological Research · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted

  9. US 7569591

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  10. US 7560437

    Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase

    The Regents of the University of Colorado · Granted Jul 14, 2009 · Expires Jul 9, 2029

    granted

  11. AU 2008340179

    Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists

    AOP ORPHAN PHARMACEUTICALS AG [AT] · Granted Jul 2, 2009 · Expires Jun 27, 2029

    granted

  12. US 7547698

    Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)

    Xenon Pharmaceuticals Inc. · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted

  13. US 7547806

    Tannate salt of rasagiline

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted

  14. US 7517971

    Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity

    The Regents of the University of Colorado · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  15. US 7495014

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted

  16. US 7465784

    Antimicrobial peptides and methods of identifying the same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Dec 16, 2008 · Expires Dec 11, 2028

    granted

  17. US 7439045

    pH controlled fermentation process for pseudomonic acid production

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted

  18. US 7439373

    Crystalline mycophenolate sodium

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted

  19. US 7439252

    Ascomycin crystalline forms and preparation thereof

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted

  20. US 7431932

    Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted

  21. US 7425644

    Method of purifying pravastatin

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Sep 16, 2008 · Expires Sep 11, 2028

    granted

  22. US 7413864

    Treating cancer using a telomerase vaccine

    The Regents of the University of Colorado · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted

  23. US 7414046

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted

  24. US 7396860

    Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.